 |
News |
|
Subscriptions are no longer available for JDA.
As you may be aware, many of the papers published in JDA had previously been
published in it's sister journals; the Journal of Medical Economics, the Journal of Outcomes Research and the Journal of Clinical Research. From 2007 papers will only be available in the journal they were first published
in.
The Journal of Medical Econmics is also undergoing some exciting changes next year. Please click here for more information.
If you have any queries or would like to find out more about our other journals
please do not hesitate to contact us.
| |
|
|
The Journal of Drug Assessment |
 |
|
The Journal of Drug Assessment is a quarterly publication, available on subscription, covering all aspects
of drug evaluation.
A variety of factors – increasing health needs, cost containment measures, pressure
to provide health services efficiently – have catapulted the areas of clinical
research, medical economics and outcomes research into the front line of issues
affecting healthcare.
Those who provide and pay for healthcare services, along with the pharmaceutical
industry, must now be fully informed about the consequences of choosing a particular
therapy. Efficacy and safety are no longer the only benchmarks against which to
evaluate novel therapeutics: the scope has now broadened to include social and
economic issues as well. Indeed, failure to consider the wider implications of
a product may limit its availability and market success.
It is vital that healthcare professionals have access to high quality research
into all aspects of new and established therapeutics – which is why a subscription
to the Journal of Drug Assessment makes sense.
|
21 days from acceptance to publication | | |
|
|
|
|
|
|
|
Acceptance Criteria |
| | |
|
|
|
|
Indexing |
|
The Journal of Drug Assessment is abstracted/indexed by Cochrane library, EMBASE, BIOSIS, CINAHL, CAB Health/CAB
Abstracts, International Pharmaceutical Abstracts, Pharm-line.
| | | |
|
|
|
|
Publication Format |
|
The Journal of Drug Assessment is published quarterly. Papers may also be published as individual articles,
each bound in a journal cover.
The journals are A5 size and can be customised to suit individual requirements,
for example encapsulated product monographs or reprints in any language. Each
paper is abstracted on the Journal website.
| | |
|
